David G. Glazer advises and represents life sciences, healthcare, and technology companies in matters throughout the United States, Europe, and Asia. Working closely with clients to understand their businesses, David structures and negotiates deals to meet their objectives and find practical solutions to complex problems. He is the co-editor of the Morgan Lewis Emerging Life Sciences Companies Deskbook. David’s clients range from biotechnology startups to global Fortune 100 pharmaceutical companies.